Evidence map›Paper›PMID 25511446›Full record

ReviewMolecular neurobiology2016

Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.

Pradip K Kamat, Anuradha Kalani, Shivika Rai, Supriya Swarnkar, Santoshkumar Tota, Chandishwar Nath, Neetu Tyagi

Abstract readReview
In one paragraph

Review in Molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 243 papers.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 466 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Changes in Glutathione and Homocysteine Concentrations in Treatment-Resistant Depression After Electroconvulsive Therapy.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Pradip K KamatDivision of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, KY, 40202, USA. pkkama01@louisville.edu.
Anuradha KalaniDivision of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, KY, 40202, USA.
Shivika RaiDivision of Pharmacology, Central Drug Research Institute (CDRI), P.O. Box 173, Lucknow, 226001, UP, India.
Supriya SwarnkarScripp Institute, Jupiter, FL, 33458, USA.
Santoshkumar TotaDivision of Pharmacology, Central Drug Research Institute (CDRI), P.O. Box 173, Lucknow, 226001, UP, India.
Chandishwar NathDivision of Pharmacology, Central Drug Research Institute (CDRI), P.O. Box 173, Lucknow, 226001, UP, India.
Neetu TyagiDivision of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, KY, 40202, USA.
Central Drug Research Institute · INUniversity of Louisville Hospital · USScripps Research Institute · US

Funding

Mechanisms of Mitochondrial Dysfunction in Brain VasculatureR01HL107640 · NHLBI · UNIVERSITY OF LOUISVILLE · PI TYAGI, NEETU · 2012 to 2016
$1.8M
NHLBI NIH HHS R01 HL107640
6 · The paper itself

Abstract

Synapses are formed by interneuronal connections that permit a neuronal cell to pass an electrical or chemical signal to another cell. This passage usually gets damaged or lost in most of the neurodegenerative diseases. It is widely believed that the synaptic dysfunction and synapse loss contribute to the cognitive deficits in patients with Alzheimer's disease (AD). Although pathological hallmarks of AD are senile plaques, neurofibrillary tangles, and neuronal degeneration which are associated with increased oxidative stress, synaptic loss is an early event in the pathogenesis of AD. The involvement of major kinases such as mitogen-activated protein kinase (MAPK), extracellular receptor kinase (ERK), calmodulin-dependent protein kinase (CaMKII), glycogen synthase-3β (GSK-3β), cAMP response element-binding protein (CREB), and calcineurin is dynamically associated with oxidative stress-mediated abnormal hyperphosphorylation of tau and suggests that alteration of these kinases could exclusively be involved in the pathogenesis of AD. N-methyl-D-aspartate (NMDA) receptor (NMDAR) activation and beta amyloid (Aβ) toxicity alter the synapse function, which is also associated with protein phosphatase (PP) inhibition and tau hyperphosphorylation (two main events of AD). However, the involvement of oxidative stress in synapse dysfunction is poorly understood. Oxidative stress and free radical generation in the brain along with excitotoxicity leads to neuronal cell death. It is inferred from several studies that excitotoxicity, free radical generation, and altered synaptic function encouraged by oxidative stress are associated with AD pathology. NMDARs maintain neuronal excitability, Ca(2+) influx, and memory formation through mechanisms of synaptic plasticity. Recently, we have reported the mechanism of the synapse redox stress associated with NMDARs altered expression. We suggest that oxidative stress mediated through NMDAR and their interaction with other molecules might be a driving force for tau hyperphosphorylation and synapse dysfunction. Thus, understanding the oxidative stress mechanism and degenerating synapses is crucial for the development of therapeutic strategies designed to prevent AD pathogenesis.

Indexed as

Alzheimer DiseaseAnimalsBrainEnzyme InhibitorsHumansOxidative StressReceptors, N-Methyl-D-AspartateSynapsestau ProteinsEnzyme InhibitorsReceptors, N-Methyl-D-Aspartatetau ProteinsAlzheimer’s diseaseKinasesNMDA receptorOxidative stressSynaptic functionTau protein

Identifiers

PMID25511446
PMCPMC4470891
OpenAlexW1968602836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.